
Aspect Biosystems
@aspectbiosys
Developing bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases.
ID: 2831151169
http://www.aspectbiosystems.com 25-09-2014 04:28:10
1,1K Tweet
2,2K Followers
782 Following

Vancouver-basedΒ Aspect BiosystemsΒ is working to help incurable diseases like Type 1 diabetes. Earlier this week, government ministersΒ FranΓ§ois-Philippe Champagne (FPC) π¨π¦Β andΒ Brenda BaileyΒ expressed their support for Tamer Mohamed's innovative company with a $70 million investment. bcbusiness.ca/industries/tecβ¦


Aspect has been awarded BIOTECanada's 2024 Gold Leaf Award for Biotech Company of the Year! π This award "celebrates a distinguished organization that has made significant contributions to the Canadian biotechnology sector." Learn more: buff.ly/46XZCcj


Join CEO Tamer Mohamed (Tamer Mohamed) for a panel on "Embracing & Accelerating Biotech Innovation" at BIOTECanada's #BIONATION2024. π Tuesday September 24, 2:40pm EDT π Ottawa, ON Learn more: buff.ly/3yWbE9x #GBW2024 #biotech #CdnInnovation


CEO Tamer Mohamed (Tamer Mohamed) will present at @allliancerm's Cell & Gene Meeting on the Mesa. #CGMesa24 π October 7, 2:15pm MST π Phoenix, AZ Learn more: buff.ly/3fNyvbd


CEO Tamer Mohamed (Tamer Mohamed) sharing updates on our development of bioprinted tissue therapeutics for metabolic and endocrine diseases at Alliance for Regenerative Medicine (ARM)'s #CGMesa24


We are proud to share that CEO Tamer Mohamed (Tamer Mohamed) has joined BIOTECanada's Board of Directors. Read the full press release: buff.ly/3ZSLm3e


Join CEO Tamer Mohamed (Tamer Mohamed) for a fireside chat during the industry symposium on "Innovate to Elevate: Commercializing Regenerative Medicine in Canada" at Stem Cell Network's #TMM2024. π November 6, 1:50pm ET π MontrΓ©al, QC Learn more: buff.ly/3Afagjg


On this #WorldDiabetesDay, we could not be more committed to our mission to develop bioprinted tissue therapeutics, alongside our partner Novo Nordisk, that could transform the lives of people living with diabetes.





Pleased to see our US$115 million Series B financing highlighted at the Toronto Stock Exchange #TSX. Thank you, Canada's Markets!



Join Chief Scientific Officer Sam Wadsworth (Sam Wadsworth) for a panel on "The Promise of Cell and Gene Therapies" at Life Sciences BC's Access to Innovation conference. #LSBCaccess #CellTherapy #Biotech